Rheumatoid Arthritis
63 drugs542,825 FAERS reportsMedDRA PT
GET
/api/v1/reaction/rheumatoid-arthritisReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D001172
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Source: U.S. National Library of Medicine — MeSH (Arthritis, Rheumatoid)
Drugs reporting Rheumatoid Arthritis (63)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Cortisone5,91249%
- 2Desoximetasone8,18944%
- 3Gold2,75744%
- 4Butyrate47226%
- 5Sulfasalazine19,33125%
- 6N-acetyltyrosine125%
- 7Leflunomide25,09524%
- 8Pseudoephedrine5,21321%
- 9Tocilizumab22,49520%
- 10Methane120%
- 11Sarilumab4,50918%
- 12Hydroxychloroquine26,63018%
- 13Abatacept23,92418%
- 14Golimumab14,23917%
- 15Certolizumab Pegol19,43617%
- 16Euphorbia Resinifera Resin114%
- 17Piroxicam84113%
- 18Nabilone26513%
- 19Benzalkonium6112%
- 20Calcium Gluconate1,37312%
- 21Tofacitinib19,34210%
- 22Alendronate10,09310%
- 23Aluminum Acetate410%
- 24Anakinra1,5429.5%
- 25Neomycin6169.5%
- 26Rituximab20,0369.3%
- 27Codeine1,8148.9%
- 28Methotrexate42,4458.8%
- 29Minocycline1,4188.7%
- 30Etanercept46,3707.8%
- 31Risedronate2,3637.8%
- 32Infliximab18,6027.7%
- 33Folic Acid17,7177.2%
- 34Nortriptyline4027.2%
- 35Diclofenac10,7646.6%
- 36Meperidine5796.4%
- 37Penicillamine535.8%
- 38Celecoxib7,3155.7%
- 39Gluconate2,7035.6%
- 40Cetirizine9,2515.4%
- 41Ketoprofen6875.4%
- 42Sodium Succinate2,7325.1%
- 43Adalimumab36,5135.1%
- 44Prednisone24,6425.0%
- 45Misoprostol8044.9%
- 46Ustekinumab4,7304.7%
- 47Azathioprine3,7874.3%
- 48Moxifloxacin8364.3%
- 49Triamcinolone1,2554.1%
- 50Upadacitinib3,1524.1%
- 51Meloxicam2,2824.0%
- 52Auranofin83.9%
- 53Baricitinib3523.7%
- 54Naproxen5,9303.6%
- 55Potassium Phosphate1123.6%
- 56Methylprednisolone5,7243.4%
- 57Salsalate293.1%
- 58Progesterone6803.0%
- 59Oxaprozin252.8%
- 60Citrate4,9962.4%
- 61Sodium49,3052.3%
- 62Chromium92.0%
- 63Boric Acid61—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Joint Swelling43 shared · 0.50
- Drug Intolerance33 shared · 0.30
- Systemic Lupus Erythematosus21 shared · 0.30
- Arthropathy22 shared · 0.29
- Synovitis17 shared · 0.26
- Contraindicated Product Administered18 shared · 0.24
- Pemphigus15 shared · 0.22
- Swelling20 shared · 0.22
- Glossodynia12 shared · 0.17
- Hand Deformity10 shared · 0.15
Literature
Recent PubMed references pinned to Arthritis, Rheumatoid as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study.Rheumatology international · 2026 · Tatar OD, Kılıç L, Kalyoncu U, et al.PMID 42207304DOI 10.1007/s00296-026-06158-5
- Therapeutic Potential of Bee Venom and Capsicum annum Hydroethanolic Extract in Experimental Model of Rheumatoid Arthritis in Male Rats.Mediators of inflammation · 2026 · Hussain A, Soliman AS, Abd-Elbaset M, et al.PMID 42206805DOI 10.1155/mi/5550872
- The Role of Epithelial-Mesenchymal Transition in Oral Inflammatory Diseases.Journal of cellular physiology · 2026 · Wang Y, Yang Y, Xu C, et al.PMID 42204904DOI 10.1002/jcp.70194
- Pomolic Acid from the Dong Botanical Drug Madeng'ai Suppresses TNF-α-Induced Inflammatory Response in RA-HFLS by Inhibiting NF-κB Signaling Pathway Activation.Molecules (Basel, Switzerland) · 2026 · Huang S, Cai W, Wang Y, et al.PMID 42197115DOI 10.3390/molecules31101560
- Multi-Matrix LC-MS/MS Validation of Methotrexate Polyglutamates: Comparison of VAMS, DBS, and Conventional Blood Sampling in Rheumatoid Arthritis.International journal of molecular sciences · 2026 · Kocur A, Kajfasz M, Mikulska A, et al.PMID 42196403DOI 10.3390/ijms27104429
- The Role of Pharmacogenetics in the Effectiveness of Rheumatoid Arthritis Treatment with Leflunomide.Genes · 2026 · Plewa P, Jędrasiak A, Jerzyńska O, et al.PMID 42195031DOI 10.3390/genes17050573
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.